Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry-Reference-Cited by-同舟云学术

Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry

Published:2021-04 Issue:4 Volume:18 Page:613-622
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Kolaitis Nicholas A.¹^ORCID,Zamanian Roham T.²,de Jesus Perez Vinicio A.²,Badesch David B.³,Benza Raymond L.⁴,Burger Charles D.⁵,Chakinala Murali M.⁶,Elwing Jean M.⁷,Feldman Jeremy⁸,Lammi Matthew R.⁹,Mathai Stephen C.¹⁰,McConnell John W.¹¹,Presberg Kenneth W.¹²,Robinson Jeffrey C.¹³,Sager Jeffrey¹⁴,Shlobin Oksana A.¹⁵,Simon Marc A.¹⁶,Kawut Steven M.¹⁷,Glidden David V.¹⁸,Singer Jonathan P.¹^ORCID,De Marco Teresa¹

Affiliation:

1. Department of Medicine and

2. Department of Medicine, Stanford University School of Medicine, Palo Alto, California

3. Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado

4. Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, Pennsylvania

5. Department of Medicine, Mayo Clinic Florida, Jacksonville, Florida

6. Department of Medicine, Washington University, St. Louis, Missouri

7. Department of Medicine, University of Cincinnati, Cincinnati, Ohio

8. Arizona Pulmonary Specialists, Phoenix, Arizona

9. Comprehensive Pulmonary Hypertension Center-University Medical Center, Louisiana State University, New Orleans, Louisiana

10. Department of Medicine, Johns Hopkins University, Baltimore, Maryland

11. Kentuckiana Pulmonary Research Center, Kentuckiana Pulmonary Associates, Louisville, Kentucky

12. Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin

13. The Oregon Clinic, Portland, Oregon

14. Cottage Pulmonary Hypertension Center, Cottage Health, Santa Barbara, California

15. Advanced Lung Disease and Lung Transplant Program, Inova Fairfax Medical Campus, Falls Church, Virginia

16. Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; and

17. Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania

18. Department of Epidemiology and Biostatistics, University of California, San Francisco School of Medicine, San Francisco, California

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference42 articles.

1. Pulmonary Arterial Hypertension

2. Management of Pulmonary Arterial Hypertension

3. Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension

4. Drug-induced pulmonary arterial hypertension: a recent outbreak

5. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension;CHEST;2024-06

3. Investigating the “sex paradox” in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR);The Journal of Heart and Lung Transplantation;2024-06

4. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association;Circulation;2024-02-20

5. Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension;Cell Biology and Toxicology;2024-02-13